Skip to main content

DNA Methylation

Histone markers predict human age with accuracy comparable to DNA methylation clocks


In a recent study published in the journal Science Advances, a group of researchers investigated the role of histone modifications in human aging by developing and evaluating histone-specific age prediction models across tissues and cell types.

Background

Aging involves complex cellular and molecular changes, including epigenetic modifications like Deoxyribonucleic acid (DNA) methylation and histone marks. Age predictors, or "clocks," have been developed using DNA methylation, transcriptomics, and blood chemistry data, with methylation-based models achieving a median absolute error of ~4 years.

While histone marks offer an interpretable framework based on the histone code, their potential for constructing accurate age predictors remains underexplored. Research has shown age-related shifts in histone modifications, suggesting their utility in modeling aging. However, the study emphasizes that sample size plays a critical role in determining the accuracy and reliability of such predictors.

Further research is needed to fully understand their role and to establish histone-based clocks comparable to existing methylation-based predictors.

About the Study

Researchers collected 1,814 human tissue chromatin immunoprecipitation sequencing (ChIP-seq) samples from the Encyclopedia of DNA Elements (ENCODE) project in bigWig format to generate and interpret histone-based age predictors.

The samples included seven histone modifications: histone H3 lysine 4 trimethylation (H3K4me3), histone H3 lysine 27 acetylation (H3K27ac), histone H3 lysine 27 trimethylation (H3K27me3), histone H3 lysine 4 monomethylation (H3K4me1), histone H3 lysine 36 trimethylation (H3K36me3), histone H3 lysine 9 trimethylation (H3K9me3), and histone H3 lysine 9 acetylation (H3K9ac).

Data processing involved averaging the negative base-10 logarithm of P-values’ signals across gene bodies using Homo sapiens annotations from Ensembl release 105. Samples with substantial missing features were discarded, and missing values were encoded as zero.

Various genomic regions were analyzed, including intergenic regions and Cytosine-phosphate-Guanine (CpG) dinucleotides. Embryonic samples were encoded with gestational week adjustments, while anonymized samples over 90 were assigned an age of 90.

To test in vitro performance, 568 additional samples spanning 12 histone marks were collected. Imputed data from ENCODE’s Avocado dataset added 1,379 samples, enhancing the training dataset. Age predictors employed Elastic Net regularization-based feature selection, principal component analysis (PCA) with truncated support vector decomposition, and automatic relevance determination regression, all implemented in Python. Performance evaluation used 10-fold nested cross-validation to prevent artificially inflated accuracy metrics, excluding cancer samples.

Histone-based predictors were compared to DNA methylation-based predictors, with the study noting the impact of differences in sample size and dataset distributions on the comparison. Predictor interpretation involved gene set enrichment analysis (GSEA), selecting genes significantly contributing to age prediction accuracy. Statistical analyses employed Python packages, ensuring validation.

Study Results

Focusing on seven histone marks (H3K4me3, H3K27ac, H3K9ac, H3K9me3, H3K27me3, H3K36me3, and H3K4me1), researchers used data from 1,814 human tissue samples spanning 82 tissues and age groups ranging from embryonic stages to 90-plus years. The samples represented diverse biological contexts and were processed using standardized methods to ensure consistency and reliability.

To create age predictors, researchers reduced the dimensionality of the data by averaging negative log-transformed P-values for each histone modification across gene bodies. These values were then transformed to stabilize the variance. Uniform manifold approximation and projection (UMAP) and PCA revealed distinct clustering based on histone type, with some age-related trends emerging, particularly for samples over 70 years old.

Histone marks showed significant correlations with age, particularly the repressive marks H3K9me3 and H3K27me3, which decreased with age, and the activating mark H3K4me3, which increased. Notably, the study observed that signal variance for all histone marks increased with age, highlighting epigenetic drift as a key factor in declining regulation. These observations informed the development of multivariate age predictors using ElasticNet for feature selection, principal component analysis to reduce noise, and automatic relevance determination regression for age estimation.

The histone-specific age predictors demonstrated robust performance, with H3K4me3 achieving the highest accuracy (Pearson’s r = 0.94, median absolute error = 4.31 years). Comparisons with DNA methylation-based predictors indicated comparable accuracy, particularly for activating histone marks, though the paper notes that DNA methylation predictors often have a younger skew in sample age distributions, which can affect performance comparisons. Additional experiments with imputed and primary cell data confirmed the reliability and accuracy of the histone mark predictors.

GSEA and pathway analyses highlighted developmental processes, transcriptional regulation, and ribonucleic acid (RNA)-related pathways as key contributors to age prediction. Histone-coding genes and age-related genes such as Homeobox D8 (HOXD8), Thioredoxin Interacting Protein (TXNIP), and Period Circadian Regulator 1 (PER1) were strongly associated with histone mark changes.

The study also introduced a pan-histone, pan-tissue age predictor, which leverages shared age-related trends across histone marks. This model not only performed comparably to histone-specific predictors but also emphasized the shared epigenetic patterns across the genome that underpin aging.
Conclusions

Since the development of DNA methylation-based age predictors, biohorology has rapidly expanded, offering biomarkers like telomere length, transcriptomics, and proteomics. While DNA methylation clocks are accurate, interpreting them is often challenging due to ambiguous gene associations. In contrast, histone mark-based predictors reveal genes linked to development, circadian regulation, and aging. Using ChIP-seq data, researchers created age predictors from seven histone marks.

Crucially, the study demonstrated that models trained on one histone mark could predict age using another, underscoring the shared epigenetic information across histone modifications. This research highlights the interpretability and potential of histone mark-based predictors as a robust tool for understanding epigenetic aging and developing age estimation models.

DNA methylation, epigenetics, gene expression, cytosine modification, methyltransferases, CpG islands, histone modification, gene silencing, transcription regulation, genome stability, 5-methylcytosine, DNA demethylation, epigenomic profiling, chromatin remodeling, DNA methylation biomarkers, environmental epigenetics, DNA methylation and aging, epigenetic inheritance, epigenetic therapy, cancer epigenetics

#DNAmethylation, #Epigenetics, #GeneExpression, #CytosineModification, #Methyltransferases, #CpGIslands, #HistoneModification, #GeneSilencing, #TranscriptionRegulation, #GenomeStability, #5mC, #DNADeMethylation, #Epigenomics, #ChromatinRemodeling, #DNABiomarkers, #EnvironmentalEpigenetics, #EpigeneticsAndAging, #EpigeneticInheritance, #EpigeneticTherapy, #CancerEpigenetics

Comments

Popular posts from this blog

Fruitful innovation

Fruitful innovation: Transforming watermelon genetics with advanced base editors The development of new adenine base editors (ABE) and adenine-to-thymine/ guanine base editors (AKBE) is transforming watermelon genetic engineering. These innovative tools enable precise A:T-to-G and A:T-to-T base substitutions, allowing for targeted genetic modifications. The research highlights the efficiency of these editors in generating specific mutations, such as a flowerless phenotype in ClFT (Y84H) mutant plants. This advancement not only enhances the understanding of gene function but also significantly improves molecular breeding, paving the way for more efficient watermelon crop improvement. Traditional breeding methods for watermelon often face challenges in achieving desired genetic traits efficiently and accurately. While CRISPR/Cas9 has provided a powerful tool for genome editing, its precision and scope are sometimes limited. These limitations highlight the need for more advanced gene-e...

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...

Genetics study on COVID-19

Large genetic study on severe COVID-19 Bonn researchers confirm three other genes for increased risk in addition to the known TLR7 gene Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn (UKB) and the University of Bonn, in cooperation with other research teams from Germany, the Netherlands, Spain and Italy, investigated a particularly large group of affected individuals. They confirmed the central and already known role of the TLR7 gene in severe courses of the disease in men, but were also able to find evidence for a contribution of the gene in women. In addition, they were able to show that genetic changes in three other genes of the innate immune system contribute to severe COVID-19. The results have now been published in the journal " Human Genetics and Genomics Advances ". Even though the number of severe cases following infection with the SARS-CoV-...